Insurers pay more for multiple sclerosis drug because rebates don’t help, report says
(By Ed Silverman for ST A T) D rug makers may offer rebates to payers, but health plans continue to
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Ed Silverman for ST A T) D rug makers may offer rebates to payers, but health plans continue to
Read moreThe long-term dilemma faced by the Social Security and Medicare Trust Funds is not a self-correcting situation, and most Americans
Read more(By Henry A . Waxman and Bill Corr for ST A T) S uperbugs, disease-causing microbes that have mutated to
Read more(By Rebecca Robbins for ST A T) T he insulin market, dominated by old drugs that have skyrocketed in price
Read more(By Rina Shalkh-Lasko for NPR) Many countries think of TB as a disease of the past and this lack of
Read moreThe annual Medicare Open Enrollment period, which runs through December 7, provides an opportunity to re-examine your Part D drug
Read moreMedicare expert Philip Moeller, in a post today on philly.com, provides a synopsis of several key areas where Medicare participants
Read moreTodd Campbell of Motley Fool takes a look at the changes in store for Medicare Advantage participants in 2017 in
Read more(By Damian Garde for ST A T) S cientists at Eli Lilly are racing to wrap up a clinical trial
Read more(By Kelly Gooch for Becker’s Hospital Review) Breast cancer chemotherapy costs vary widely across the United States, with patients taking
Read more